Why the study?
Does nicorandil or glyceryl trinitrate reduce infarct size in a dog model of ischemia-reperfusion, and are these effects mediated by KATP channels or guanylate cyclase?
Does nicorandil or glyceryl trinitrate reduce infarct size in a dog model of ischemia-reperfusion, and are these effects mediated by KATP channels or guanylate cyclase?
In a canine model of ischemia-reperfusion, nicorandil reduces infarct size via opening of myocardial KATP channels, whereas glyceryl trinitrate provides cardioprotection via guanylate cyclase activation.
No takes yet. Share an insight, caveat, or question.
Supports KATP-mediated cardioprotection by nicorandil in canine ischemia-reperfusion; leaves open human translation.
Tsuneo Mizumura (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: